Package 59762-0407-4

Brand: risedronate sodium

Generic: risedronate sodium
NDC Package

Package Facts

Identity

Package NDC 59762-0407-4
Digits Only 5976204074
Product NDC 59762-0407
Description

1 BLISTER PACK in 1 CARTON (59762-0407-4) / 4 TABLET, DELAYED RELEASE in 1 BLISTER PACK

Marketing

Marketing Status
Marketed Since 2018-03-02
Brand risedronate sodium
Generic risedronate sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "38140640-1e32-4a68-8d8d-3eb52ab4af01", "openfda": {"unii": ["HU2YAQ274O", "F67L43UT5C"], "rxcui": ["1020064", "1020065"], "spl_set_id": ["c89430be-15f1-4b8b-ab7e-738de716ee7d"], "manufacturer_name": ["Mylan Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BLISTER PACK in 1 CARTON (59762-0407-4)  / 4 TABLET, DELAYED RELEASE in 1 BLISTER PACK", "package_ndc": "59762-0407-4", "marketing_start_date": "20180302"}], "brand_name": "Risedronate Sodium", "product_id": "59762-0407_38140640-1e32-4a68-8d8d-3eb52ab4af01", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Bisphosphonate [EPC]", "Bisphosphonate [EPC]", "Diphosphonates [CS]", "Diphosphonates [CS]"], "product_ndc": "59762-0407", "generic_name": "risedronate sodium", "labeler_name": "Mylan Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Risedronate Sodium", "active_ingredients": [{"name": "RISEDRONATE SODIUM HEMIPENTAHYDRATE", "strength": "30.1 mg/1"}, {"name": "RISEDRONATE SODIUM MONOHYDRATE", "strength": "4.9 mg/1"}], "application_number": "NDA022560", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20180302", "listing_expiration_date": "20261231"}